These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
546 related items for PubMed ID: 10928218
1. Differences in the capacity of several biochemical bone markers to assess high bone turnover in early menopause and response to alendronate therapy. Fink E, Cormier C, Steinmetz P, Kindermans C, Le Bouc Y, Souberbielle JC. Osteoporos Int; 2000; 11(4):295-303. PubMed ID: 10928218 [Abstract] [Full Text] [Related]
2. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial. Greenspan SL, Parker RA, Ferguson L, Rosen HN, Maitland-Ramsey L, Karpf DB. J Bone Miner Res; 1998 Sep; 13(9):1431-8. PubMed ID: 9738515 [Abstract] [Full Text] [Related]
4. Comparison of bone and total alkaline phosphatase and bone mineral density in postmenopausal osteoporotic women treated with alendronate. Watts NB, Jenkins DK, Visor JM, Casal DC, Geusens P. Osteoporos Int; 2001 Sep; 12(4):279-88. PubMed ID: 11420777 [Abstract] [Full Text] [Related]
9. Bisphosphonates for prevention of postmenopausal osteoporosis. Ravn P. Dan Med Bull; 2002 Feb; 49(1):1-18. PubMed ID: 11894721 [Abstract] [Full Text] [Related]
10. The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation. Rosen CJ, Chesnut CH, Mallinak NJ. J Clin Endocrinol Metab; 1997 Jun; 82(6):1904-10. PubMed ID: 9177404 [Abstract] [Full Text] [Related]
11. Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis. Chen P, Satterwhite JH, Licata AA, Lewiecki EM, Sipos AA, Misurski DM, Wagman RB. J Bone Miner Res; 2005 Jun; 20(6):962-70. PubMed ID: 15883636 [Abstract] [Full Text] [Related]
12. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study. Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, Cormier C, Bréart G, Meunier PJ, Delmas PD. J Bone Miner Res; 1996 Oct; 11(10):1531-8. PubMed ID: 8889854 [Abstract] [Full Text] [Related]
13. The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women. Chaki O, Yoshikata I, Kikuchi R, Nakayama M, Uchiyama Y, Hirahara F, Gorai I. J Bone Miner Res; 2000 Aug; 15(8):1537-44. PubMed ID: 10934652 [Abstract] [Full Text] [Related]
14. Relationship of bone turnover to bone density and fractures. Melton LJ, Khosla S, Atkinson EJ, O'Fallon WM, Riggs BL. J Bone Miner Res; 1997 Jul; 12(7):1083-91. PubMed ID: 9200008 [Abstract] [Full Text] [Related]
15. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women. Papakitsou EF, Margioris AN, Dretakis KE, Trovas G, Zoras U, Lyritis G, Dretakis EK, Stergiopoulos K. Maturitas; 2004 Mar 15; 47(3):185-93. PubMed ID: 15036488 [Abstract] [Full Text] [Related]
19. Biochemical markers can predict the response in bone mass during alendronate treatment in early postmenopausal women. Alendronate Osteoporosis Prevention Study Group. Ravn P, Clemmesen B, Christiansen C. Bone; 1999 Mar 15; 24(3):237-44. PubMed ID: 10071916 [Abstract] [Full Text] [Related]
20. Bone resorption in post-menopausal women with normal and low BMD assessed with biochemical markers specific for telopeptide derived degradation products of collagen type I. Reginster JY, Henrotin Y, Christiansen C, Gamwell-Henriksen E, Bruyere, Collette J, Christgau S. Calcif Tissue Int; 2001 Sep 15; 69(3):130-7. PubMed ID: 11683527 [Abstract] [Full Text] [Related] Page: [Next] [New Search]